In cancerous cells, the ubiquitination of specific RPs can promote tumour invasion, tumour metastasis, and resistance to chemotherapy treatment, thereby contributing to tumour progression (see sections on RPL5, RPL11, RPS3, and RPL23a). The gene discussed is RPS3; the disease is neoplasm.